These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16921591)

  • 1. Case 15-2006: the Budd-Chiari syndrome and V617F mutation in JAK2.
    Darwish Murad S; Janssen HL
    N Engl J Med; 2006 Aug; 355(7):737-8; author reply 738. PubMed ID: 16921591
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation.
    Attwell A; Ludkowski M; Nash R; Kugelmas M
    Aliment Pharmacol Ther; 2004 Oct; 20(8):867-73. PubMed ID: 15479358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budd-Chiari syndrome treated with transjugular intrahepatic portosystemic shunt.
    Das HS; Punamiya S; Kalokhe S; Desai N; Amarapurkar D; Sawant P
    J Assoc Physicians India; 2003 Mar; 51():309-10. PubMed ID: 12839361
    [No Abstract]   [Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
    Olliff SP
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome.
    Wu X; Ding W; Cao J; Han J; Li J
    Int J Clin Pract; 2010 Mar; 64(4):460-4. PubMed ID: 18435742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
    Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
    Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome with extensive occlusion of the hepatic veins].
    Wu XJ; Cao JM; Han JM; Li JS
    Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1029-32. PubMed ID: 17074238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of treatment of acute Budd-Chiari syndrome with a transjugular intrahepatic portosytemic shunt.
    Blokzijl H; de Knegt RJ
    Hepatology; 2002 Jun; 35(6):1551-2. PubMed ID: 12029648
    [No Abstract]   [Full Text] [Related]  

  • 9. Late intrahepatic hematoma complicating transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome.
    Terreni N; Vangeli M; Raimondo ML; Tibballs JM; Patch D; Burroughs AK
    Cardiovasc Intervent Radiol; 2007; 30(2):335-8. PubMed ID: 17206393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Budd-Chiari syndrome].
    Plessier A
    Rev Med Interne; 2013 Dec; 34(12):741-5. PubMed ID: 24262409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budd-Chiari syndrome and essential thrombocythemia in a child: favorable outcome after transjugular intrahepatic portosystemic shunt.
    Hermeziu B; Franchi-Abella S; Plessier A; Habes D; Mosca A; Sibert A; Bernard O; Pariente D; Jacquemin E
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):334-7. PubMed ID: 18376254
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis, treatment and evolution of the Budd-Chiari syndrome: a single center experience].
    Solari J; Bandi JC; Galdame O; Marciano S; Mullen E; Garcia MR; Nucifora E; de Santibañes E; Gadano A
    Acta Gastroenterol Latinoam; 2010 Sep; 40(3):225-35. PubMed ID: 21053481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case 15-2006: the Budd-Chiari syndrome and V617F mutation in JAK2.
    Sheth AA
    N Engl J Med; 2006 Aug; 355(7):738; author reply 738. PubMed ID: 16921592
    [No Abstract]   [Full Text] [Related]  

  • 14. Transjugular Intrahepatic Portosystemic Shunt (TIPS), the preferred therapeutic option for Budd Chiari syndrome associated with portal vein thrombosis.
    Senzolo M; Cholongitas E; Davies N; Marelli L; Shusang V; Patch D; Burroughs AK
    Am J Gastroenterol; 2006 Sep; 101(9):2163-4; author reply 2164-5. PubMed ID: 16968512
    [No Abstract]   [Full Text] [Related]  

  • 15. Budd-Chiari syndrome: is TIPS tops?
    Sanyal AJ
    Am J Gastroenterol; 1999 Mar; 94(3):559-61. PubMed ID: 10086632
    [No Abstract]   [Full Text] [Related]  

  • 16. SIR 2006 Annual Meeting Film Panel Case: Budd-Chiari syndrome in a patient with Cogan syndrome.
    O'Brien MJ; Bloom A; LaBerge JM; Roberts JP; Rosenthal P; Kerlan RK;
    J Vasc Interv Radiol; 2006 Dec; 17(12):1881-3. PubMed ID: 17185682
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical decision making in acute Budd Chiari Syndrome.
    McKnight L; Chandok N; Hernandez-Alejandro R
    Ann Hepatol; 2010; 9(4):473-4. PubMed ID: 21057171
    [No Abstract]   [Full Text] [Related]  

  • 18. Extracorporeal portosystemic shunt in secondary Budd-Chiari syndrome.
    Meyer BC; Hinrichs JB; Ivanyi P; Ehrlich S; Greer M; Hoeper MM; Busch M
    J Hepatol; 2020 Oct; 73(4):974-976. PubMed ID: 32684366
    [No Abstract]   [Full Text] [Related]  

  • 19. [The Budd-Chiari syndrome in a patient with primary thrombocythemia treated with interferon alfa and transjugular portosystemic shunt].
    Brunerová L; Bartáková H; Jankovská M; Cieslarová B; Hůlek P; Kozák T; Andĕl M
    Cas Lek Cesk; 2004; 143(3):198-201. PubMed ID: 15134042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple regeneration nodes in the temporal follow-up of Budd-Chiari syndrome after TIPS].
    Pennekamp W; Willert J; Wittl E
    Rofo; 2011 Mar; 183(3):288-90. PubMed ID: 21113869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.